Corteva (CTVA)
NYSEMaterialsAgricultural InputsSnapshot 2026-07-07
$86.77+0.44%
Close 2026-07-07 · 1-day change
Reading CTVA? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CTVA free→NYSEMaterialsAgricultural InputsSnapshot 2026-07-07
Reading CTVA? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CTVA free→Warn: Management is running behind on a stated commitment.
Corteva grows seed and crop protection sales steadily. Operating EBITDA is guided near $4.1 billion in 2026. The planned seed business spin-off is on track for late 2026. New product partnerships boost crop protection revenue.
Pricing pressures and cost challenges could hurt margins. The spin-off may face delays or operational disruptions. Revenue growth is modest, near 4%, which may disappoint if costs rise.
The stock trades about 25% above our fair value near $69, reflecting roughly 4% revenue growth. Our fair value is 24% below the Street median, which is more optimistic. We see risk in margin and execution.
Breaks if: Crop Protection net sales fall below $1.78 billion
Drive growth in Crop Protection segment through volume gains in new products and biologicals despite pricing pressures, aiming for organic sales growth and margin expansion.
Standing thesis, reviewed periodically — not a price target or advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 4 of last 4 quarters. Crop Protection net sales grew from approximately $1.78 billion in 2025-Q2 to $1.88 billion in 2026-Q1, with organic sales growth between 3% and 9%. Volume gains in new products and biologicals have driven growth despite pricing pressures, indicating delivery on this priority.
“Crop Protection net sales increased 10% and organic sales increased 4%, driven by volume growth in new products and biologicals.”
“Crop Protection net sales increased 2% and organic sales increased 3%, with volume up 5% driven by demand for new products and biologicals.”
“Crop Protection net sales increased 4% and organic sales increased 3%, volume increased 7% driven by new products and biologicals demand.”
“Crop Protection net sales increased 8% and organic sales increased 9%, volume increased 11% driven by demand for new products and biologicals.”
Breaks if: Operating EBITDA falls below $4.0 billion
Maintain full-year 2026 financial guidance with Operating EBITDA expected between $4.0 billion and $4.2 billion and Operating EPS between $3.45 and $3.70 per share.
Reaffirmed in 3 of last 3 quarters. Full-year 2026 Operating EBITDA guidance remains steady at $4.0 to $4.2 billion, and Operating EPS guidance at $3.45 to $3.70 per share. This matches management's stated outlook and reflects a stable trajectory consistent with prior guidance.
“The Company reaffirmed full-year 2026 guidance with Operating EBITDA expected to be $4.0 billion to $4.2 billion.”
“The Company refined full-year 2026 guidance and expects operating EBITDA to be $4.0 to $4.2 billion.”
“The Company provided a preliminary view of 2026 and expects Operating EBITDA to be $4.1 billion at the midpoint.”
Breaks if: Spin-off delayed beyond 2026-Q4
Execute the spin-off of the seed business into an independent, publicly traded company by the fourth quarter of 2026, achieving key milestones including leadership appointments and regulatory filings.
Stated as a priority in 4 of last 4 quarters. Management consistently reaffirmed the planned separation by the second half of 2026, with key milestones such as CEO appointment, Form 10 filing, and brand launch achieved by 2026-Q1. The trajectory is delivering as planned toward the 2026-Q4 completion.
“Corteva remains on track to complete the planned separation in the second half of 2026, with already announced key milestones.”
“Corteva remains on track to complete the planned separation in the second half of 2026.”
“The planned separation in the second half of 2026 is driven by our belief it will create long-term value.”
“The Company plans to complete the separation in the second half of 2026.”
Breaks if: Seed net sales fall below $4.54 billion
Grow Seed segment revenue and improve operating EBITDA through price/mix gains, volume growth, and productivity improvements across regions.
Stated in 4 of last 4 quarters. Seed net sales showed growth with organic sales increasing from 6% to 31% across quarters, driven by volume and price/mix gains. Segment operating EBITDA improved, reflecting delivery on this priority.
“Seed net sales increased 12% and organic sales increased 9%, driven by volume growth and price/mix gains.”
“Seed net sales increased 4% and organic sales increased 5%, price/mix up 3%, volume up 2%.”
“Seed net sales increased 33% and organic sales increased 31%, volume up 27%, price/mix up 4%.”
“Seed net sales increased 5% and organic sales increased 6%, price up 3%, volume up 3%.”